Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SPP 86 is a RET inhibitor (IC50 = 0.008 µM).1 It is selective for RET over a panel of 44 serine/threonine/tyrosine kinases at 10 µM but does inhibit nine by greater than 75%. SPP 86 is also selective for RET over a panel of 63 receptor and non-receptor tyrosine kinases at 0.4 µM but does inhibit six, including RET, by greater than 75%. SPP 86 reduces the proliferation of HCT116 colon cancer and TPC-1 thyroid carcinoma cells (EC50s = 2.4 and 3.3 µM, respectively). It inhibits viral replication in BHK-21 cells infected with foot-and-mouth disease virus (FMDV) when used at a concentration of 5 µM.2
WARNING This product is not for human or veterinary use.
1. Preparation of 3-
2. FGFR1-